Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
Year: 2018
Type: article
Study design: Case Report
Abstract: Key Points Core-binding factor AML can evolve from good-risk disease into aggressive disease through the gain of additional genomic aberrations. In this unique case, an AML patient died of hypereosinophilic syndrome with solid organ infiltration of differentiated eosinophils.
Source: Blood Advances
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,800
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2810219246
